Korro Bio (KRRO) Other financing activities (2018 - 2026)

Korro Bio's Other financing activities history runs 8 years deep, the most recent figure standing at $17000.0 for Q1 2026.

• Quarterly Other financing activities changed N/A year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $702000.0 (down 99.58% YoY) and the FY2025 annual result came in at $685000.0, down 98.98% from the prior year.
• Other financing activities was $17000.0 for Q1 2026 at Korro Bio, down from $685000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $100.0 million in Q4 2024 and bottomed at -$351000.0 in Q4 2023.
• A 5-year average of $12.0 million and a median of $139000.0 in 2022 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities slumped 13300.0% — and 2024, when it jumped 28590.03%.
• Korro Bio's Other financing activities stood at -$134000.0 in 2022, then plunged by 161.94% to -$351000.0 in 2023, then soared by 28590.03% to $100.0 million in 2024, then sank by 99.32% to $685000.0 in 2025, then sank by 97.52% to $17000.0 in 2026.
• Business Quant data shows KRRO's Other financing activities at $17000.0 in Q1 2026, $685000.0 in Q4 2025, and -$177000.0 in Q3 2025.